BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin HY, Yang MC, Huang CH, Wu WJ, Yu TJ, Lung FW. Polymorphisms of TP53 are markers of bladder cancer vulnerability and prognosis. Urol Oncol 2013;31:1231-41. [PMID: 22178231 DOI: 10.1016/j.urolonc.2011.11.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Almutairi MH, Almutairi BO, Alrubie TM, Alharbi SN, Parine NR, Alrefaei AF, Aldeailej I, Alamri A, Semlali A. Association between tobacco substance usage and a missense mutation in the tumor suppressor gene P53 in the Saudi Arabian population. PLoS One 2021;16:e0245133. [PMID: 33481818 DOI: 10.1371/journal.pone.0245133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Pouladi N, Abdolahi S, Farajzadeh D, Hosseinpour Feizi MA. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer. PLoS One 2019;14:e0220727. [PMID: 31387111 DOI: 10.1371/journal.pone.0220727] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
3 Zhang L, Wang Y, Qin Z, Li R, Cong R, Ji C, Meng X, Wang Y, Xia J, Song N. TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status. J Cancer 2018;9:3522-31. [PMID: 30310509 DOI: 10.7150/jca.26264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Mishchuk YM, Kharkivska YV, Serga SV, Shklyar SY, Stakhovskyi OE, Stakhovskyi EO, Vitruk YV, Kononenko AA, Demydov SV, Ostapchenko LI, Kozeretska IA. Association of TP53 Arg72Pro polymorphism (rs1042522) with bladder cancer risk in the Ukrainian population. Fakt eksp evol org 2018;23:214-218. [DOI: 10.7124/feeo.v23.1017] [Reference Citation Analysis]
5 Payandeh M, Sadeghi M, Sadeghi E. Characteristics of Patients With Transitional Cell Carcinoma of the Urinary Bladder in Kermanshah Province, Iran. Iran J Cancer Prev 2015;8:e4038. [PMID: 26855723 DOI: 10.17795/ijcp-4038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Pineda S, Milne RL, Calle ML, Rothman N, López de Maturana E, Herranz J, Kogevinas M, Chanock SJ, Tardón A, Márquez M, Guey LT, García-Closas M, Lloreta J, Baum E, González-Neira A, Carrato A, Navarro A, Silverman DT, Real FX, Malats N. Genetic variation in the TP53 pathway and bladder cancer risk. a comprehensive analysis. PLoS One 2014;9:e89952. [PMID: 24818791 DOI: 10.1371/journal.pone.0089952] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]